These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35866149)

  • 1. Cyclic Adenosine Monophosphate (cAMP)-Dependent Phosphodiesterase Inhibition Promotes Bone Anabolism Through CD8
    Roser-Page S; Weiss D; Vikulina T; Yu M; Pacifici R; Weitzmann MN
    JBMR Plus; 2022 Jul; 6(7):e10636. PubMed ID: 35866149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4Ig (abatacept) balances bone anabolic effects of T cells and Wnt-10b with antianabolic effects of osteoblastic sclerostin.
    Roser-Page S; Vikulina T; Weiss D; Habib MM; Beck GR; Pacifici R; Lane TF; Weitzmann MN
    Ann N Y Acad Sci; 2018 Mar; 1415(1):21-33. PubMed ID: 29500936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model.
    Roser-Page S; Vikulina T; Zayzafoon M; Weitzmann MN
    Arthritis Rheumatol; 2014 Apr; 66(4):990-9. PubMed ID: 24757150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells.
    Tokoyoda K; Tsujikawa K; Matsushita H; Ono Y; Hayashi T; Harada Y; Abe R; Kubo M; Yamamoto H
    Int Immunol; 2004 May; 16(5):643-53. PubMed ID: 15096485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway.
    Borger P; Kauffman HF; Postma DS; Vellenga E
    Blood; 1996 Jan; 87(2):691-8. PubMed ID: 8555492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells.
    Kanda N; Watanabe S
    Biochem Pharmacol; 2001 Aug; 62(4):495-507. PubMed ID: 11448460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
    Sinha B; Semmler J; Eisenhut T; Eigler A; Endres S
    Eur J Immunol; 1995 Jan; 25(1):147-53. PubMed ID: 7843225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bucladesine, pentoxifylline, and H-89 as cyclic adenosine monophosphate analog, phosphodiesterase, and protein kinase A inhibitor on acute pain.
    Salehi F; Hosseini-Zare MS; Aghajani H; Seyedi SY; Hosseini-Zare MS; Sharifzadeh M
    Fundam Clin Pharmacol; 2017 Aug; 31(4):411-419. PubMed ID: 28267871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
    Sasaki T; Kotera J; Omori K
    J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of phosphodiesterase inhibitors in the treatment of osteoporosis: Scopes for therapeutic repurposing and discovery of new oral osteoanabolic drugs.
    Porwal K; Pal S; Bhagwati S; Siddiqi MI; Chattopadhyay N
    Eur J Pharmacol; 2021 May; 899():174015. PubMed ID: 33711307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cAMP/EPAC/Akt signaling in the antiproteolytic effects of pentoxifylline on skeletal muscles of diabetic rats.
    Arcaro CA; Assis RP; Zanon NM; Paula-Gomes S; Navegantes LCC; Kettelhut IC; Brunetti IL; Baviera AM
    J Appl Physiol (1985); 2018 Mar; 124(3):704-716. PubMed ID: 29357512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Anabolic Effect of Calcitriol with Osteoclast-Derived Wnt 10b Secretion.
    Lu CL; Shyu JF; Wu CC; Hung CF; Liao MT; Liu WC; Zheng CM; Hou YC; Lin YF; Lu KC
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30149605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.
    Ahlström M; Lamberg-Allardt C
    J Bone Miner Res; 1997 Feb; 12(2):172-8. PubMed ID: 9041048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphodiesterase inhibitor, pentoxifylline, alters rat intestinal epithelial cell proliferation via changes in the expression of transforming growth factors.
    Diab-Assef M; Reimund JM; Ezenfis J; Duclos B; Kedinger M; Foltzer-Jourdainne C
    Scand J Gastroenterol; 2002 Feb; 37(2):206-14. PubMed ID: 11843059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera toxin enhances interleukin-17A production in both CD4
    Tsai HC; Velichko S; Lee S; Wu R
    Immunology; 2018 Jul; 154(3):500-509. PubMed ID: 29377102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
    Michie AM; Rena G; Harnett MM; Houslay MD
    Cell Biochem Biophys; 1998; 28(2-3):161-85. PubMed ID: 9515165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of CD40 ligand costimulation promotes bone formation and accretion of vertebral bone mass in mice.
    Roser-Page S; Vikulina T; Yu K; McGee-Lawrence ME; Weitzmann MN
    Rheumatology (Oxford); 2018 Jun; 57(6):1105-1114. PubMed ID: 29522194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist-Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells.
    Patel BS; Prabhala P; Oliver BG; Ammit AJ
    Am J Respir Cell Mol Biol; 2015 May; 52(5):634-40. PubMed ID: 25296132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-β Signaling and Activation of cAMP/PKA Signaling.
    Wójcik-Pszczoła K; Chłoń-Rzepa G; Jankowska A; Ślusarczyk M; Ferdek PE; Kusiak AA; Świerczek A; Pociecha K; Koczurkiewicz-Adamczyk P; Wyska E; Pękala E; Gosens R
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.